Diabetic conditions downregulate the expression of CD2AP in podocytes via PI3-K/Akt signalling

Diabetes/Metabolism Research and Reviews

Volumn 31, Issue 1, 2015, Pages 50-60

  Ha, Tae Sun ^a   Hong, Eun Jeong ^a   Han, Gi Dong ^b  

^a Chungbuk National University College of Medicine   (South Korea)

^b Yeungnam University   (South Korea)

Author keywords

Advanced glycosylation end products; CD2AP; Diabetic nephropathy; Glomerular epithelial cells; PI3 K Akt signalling; Podocyte

Indexed keywords

2 MORPHOLINO 8 PHENYLCHROMONE; ADVANCED GLYCATION END PRODUCT; CD2 ASSOCIATED PROTEIN; GLUCOSE; MESSENGER RNA; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; CD2-ASSOCIATED PROTEIN; CYTOSKELETON PROTEIN; ONCOPROTEIN; SIGNAL TRANSDUCING ADAPTOR PROTEIN; STREPTOZOCIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONFOCAL MICROSCOPY; CONTROLLED STUDY; DIABETIC NEPHROPATHY; DISEASE DURATION; DOWN REGULATION; EPITHELIUM CELL; GENE EXPRESSION; KIDNEY PARENCHYMA; MOUSE; NONHUMAN; PODOCYTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; STREPTOZOTOCIN-INDUCED DIABETES MELLITUS; WESTERN BLOTTING; ANIMAL; CELL CULTURE; DRUG EFFECTS; EXPERIMENTAL DIABETES MELLITUS; GENETICS; METABOLISM; PATHOLOGY; PHYSIOLOGY;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ANIMALS; CELLS, CULTURED; CYTOSKELETAL PROTEINS; DIABETES MELLITUS, EXPERIMENTAL; DOWN-REGULATION; GLUCOSE; MICE; ONCOGENE PROTEIN V-AKT; PHOSPHATIDYLINOSITOL 3-KINASES; PODOCYTES; RATS; SIGNAL TRANSDUCTION; STREPTOZOCIN;

EID: 84920972821     PISSN: 15207552     EISSN: 15207560     Source Type: Journal    
DOI: 10.1002/dmrr.2562     Document Type: Article

References (35)

1. Parving HH, Mauer M, Rossing P, Ritz E. Diabetic nephropathy. In The Kidney, Brenner BM (ed). WB Saunders: Philadelphia, PA, 2011; 1411-1454.
2. Sharma K, Ziyadeh FN. Biochemical events and cytokine interactions linking glucose metabolism to the development of diabetic nephropathy. Sem Nephrol 1997; 17: 80-92.
3. Vlassara H. Protein glycation in the kidney: role in diabetes and aging. Kidney Int 1996; 49: 1795-1804.
4. Mundel P, Kriz W. Structure and function of podocytes: an update. Anat Embryol (Berl) 1995; 192: 385-397.
5. Asanuma K, Mundel P. The role of podocytes in glomerular pathobiology. Clin Exp Nephrol 2003; 7: 255-259.
6. Dustin ML, Olszowy MW, Holdorf AD, et al. A novel adaptor protein orchestrates receptor patterning and cytoskeletal polarity in T-cell contacts. Cell 1998; 94: 667-677.
7. Shih NY, Li J, Karpitskii V, et al. Congenital nephrotic syndrome in mice lacking CD2-associated protein. Science 1999; 286: 312-315.
8. Li C, Ruotsalainen V, Tryggvason K, Shaw AS, Minerr JH. CD2AP is expressed with nephrin in developing podocytes and is found widely in mature kidney and elsewhere. Am J Physiol Renal Physiol 2000; 279: F785-F792.
9. Shih NY, Li J, Cotran R, Mundel P, Miner JH, Shawa AS. CD2AP localizes to the slit diaphragm and binds to nephrin via a novel C-terminal domain. Am J Pathol 2001; 159: 2303-2308.
10. Schwarz K, Simons M, Reiser J, et al. Podocin, a raft-associated component of the glomerular slit diaphragm, interacts with CD2AP and nephrin. J Clin Invest 2001; 108: 1621-1629.
11. Shaw AS, Miner JH. CD2-associated protein and the kidney. Curr Opin Nephrol Hypertens 2001; 10: 19-22.
12. Coffer PJ, Jin J, Woodgett JR. Protein kinase B (c-Akt): a multifunctional mediator of phosphatidylinositol 3-kinase activation. Biochem J 1998; 335: 1-13.
13. Fruman DA, Cantley LC. Phosphoinositide 3-kinase in immunological systems. Semin Immunol 2002; 14: 7-18.
14. Foster FM, Traer CJ, Abraham SM, Fry MJ. The phosphoinositide (PI) 3-kinase family. J Cell Sci 2003; 116: 3037-3040.
15. Ha TS. High glucose and advanced glycosylation endproducts increased podocytes permeability via PI3K/Akt signaling. J Mol Med 2010; 88: 391-400.
16. Kreisberg JI, Hoover RL, Karnovsky MJ. Isolation and characterization of rat glomerular epithelial cells in vitro. Kidney Int 1978; 14: 21-30.
17. Pegoraro AA, Singh AK, Arruda JA, Dunea G, Bakir AA. A simple method to detect an albumin permeability factor in the idiopathic nephrotic syndrome. Kidney Int 2000; 58: 1342-1345.
18. Ha TS, Song CJ, Lee JH. Effects of advanced glycosylation endproducts on perlecan core protein of glomerular epithelium. Pediatr Nephrol 2004; 19: 1219-1224.
19. Mundel P, Reiser J, Zuniga Mejia Borja A, et al. Rearrangements of the cytoskeleton and cell contacts induce process formation during differentiation of conditionally immortalized mouse podocyte cell lines. Exp Cell Res 1997; 236: 248-258.
20. Kirsch KH, Georgescu MM, Ishimaru S, Hanafusa H. CMS: an adapter molecule involved in cytoskeletal rearrangements. Proc Natl Acad Sci U S A 1999; 25: 6211-6216.
21. Welsch T, Endlich N, Kriz W, Endlich K. CD2AP and p130Cas localize to different F-actin structures in podocytes. Am J Physiol Renal Physiol 2001; 281: F769-F777.
22. Seidler J, Durzok R, Brakebusch C, Cordes N. Interactions of the integrin subunit beta1A with protein kinase B/Akt, p130Cas and paxillin contribute to regulation of radiation survival. Radiother Oncol 2005; 76: 129-134.
23. Huber TB, Hartleben B, Kim J, et al. Nephrin and CD2AP associate with phosphoinositide 3-OH kinase and stimulate AKT-dependent signaling. Mol Cell Biol 2003; 23: 4917-4928.
24. Faul C, Asanuma K, Yanagida-Asanuma E, Kim K, Mundel P. Actin up: regulation of podocyte structure and function by components of the actin cytoskeleton. Trends Cell Biol 2007; 17: 428-437.
25. Kim JM, Wu H, Green G, et al. CD2-associated protein haploinsufficiency is linked to glomerular disease susceptibility. Science 2003; 300: 1298-1300.
26. Schiffer M, Mundel P, Shaw AS, Bottinger EP. A novel role for the adaptor molecule CD2-associated protein in transforming growth factor-β-induced apoptosis. J Biol Chem 2004; 279: 37004-37012.
27. Woroniecki RP, Schiffer M, Shaw AS, Kaskel FJ, Bottinger EP. Glomerular expression of transforming growth factor- β (TGF- β) isoforms in mice lacking CD2-associated protein. Pediatr Nephrol 2006; 21: 333-338.
28. Xavier S, Niranjan T, Krick S, et al. TbetaRI independently activates Smad- and CD2AP-dependent pathways in podocytes. J Am Soc Nephrol 2009; 20: 2127-2137.
29. He F, Chen S, Wang H, et al. Regulation of CD2-associated protein influences podocyte endoplasmic reticulum stress-mediated apoptosis induced by albumin overload. Gene 2011. doi:10.1016/j.gene.2011.05.025.
30. Zhang C, Jiang HJ, Chang Y, et al. Downregulation of CD2-associated protein impaired the physiological functions of podocytes. Cell Biol Int 2009; 33: 632-639.
31. Yaddanapudi S, Altintas MM, Kistler AD, et al. CD2AP in mouse and human podocytes controls a proteolytic program that regulates cytoskeletal structure and cellular survival. J Clin Invest 2011; 121: 3965-3980.
32. Lowik MM, Groenen PJ, Pronk I, et al. Focal segmental glomerulosclerosis in a patient homozygous for a CD2AP mutation. Kidney Int 2007; 72: 1198-1203.
33. Mao J, Zhang Y, Du L, Dai Y, Yang C, Liang L. Expression profile of nephrin, podocin, and CD2AP in Chinese children with MCNS and IgA nephropathy. Pediatr Nephrol 2006; 21: 1666-1675.
34. Coward RJ, Foster RR, Patton D, et al. Nephrotic plasma alters slit diaphragm-dependent signaling and translocates nephrin, podocin, and CD2 associated protein in cultured human podocytes. J Am Soc Nephrol 2005; 16: 629-637.
35. Lydia A, Asanuma K, Nonaka K, et al. Effects of 22-oxa-calcitriol on podocyte injury in adriamycin-induced nephrosis. Am J Nephrol 2012; 35: 58-68.